A lateral flow test is a portable diagnostic device that detects a specific substance in a sample, usually by identifying proteins (antigens) rather than genetic material. Most people became familiar with these tests during the COVID-19 pandemic, but the technology has been used for decades in pregnancy tests, strep throat screens, HIV rapid tests, and drug testing kits. The test delivers a visual result in minutes, requires no laboratory equipment, and can be performed at home.
How the Test Works
The basic science behind a lateral flow test combines two principles: capillary action and antibody-antigen binding. When you apply a sample (a nasal swab mixed in buffer solution, a drop of blood, or urine), the liquid travels across a thin membrane strip through capillary force alone, the same physical process that draws water up a paper towel. No batteries, pumps, or power sources are needed.
As the liquid moves through the strip, it picks up specially designed detector particles, often gold nanoparticles or colored latex beads. These particles are pre-coated with antibodies that bind specifically to whatever substance the test is designed to find. If the target substance is present in your sample, it latches onto these antibodies and the pair travels together down the strip. When this complex reaches a fixed line of capture antibodies (the test line), it gets trapped there, concentrating the colored particles into a visible line. If the target substance isn’t in the sample, nothing gets caught, and no line appears.
A second line further down the strip, the control line, captures detector particles regardless of whether the target substance is present. This line confirms that the liquid flowed properly through the entire device. It’s essentially a built-in quality check.
What’s Inside the Test Strip
Though the plastic cassette looks simple, the strip inside has several distinct zones, each with a specific job:
- Sample pad: The area where you apply your sample. It absorbs the liquid and begins distributing it evenly across the strip.
- Conjugate pad: Contains the dried, colored detector particles pre-loaded with antibodies. When the liquid reaches this zone, it rehydrates and mobilizes them.
- Nitrocellulose membrane: The core of the test. This membrane has high protein-binding capacity, which allows antibodies to be fixed at precise locations to form the test (T) and control (C) lines. Its wicking properties keep the liquid moving at a consistent pace through the detection zones.
- Absorbent pad: Sits at the far end and soaks up excess liquid, pulling the sample all the way through the strip and reducing background noise that could create a false signal.
Reading Your Results
Lateral flow tests display results through colored lines in a small window, typically labeled “C” for control and “T” for test. The interpretation is straightforward:
- Negative: A visible line appears at the C position only. The control line confirms the device worked properly, and the absence of a T line means the target substance was not detected.
- Positive: Visible lines appear at both the C and T positions. Even a faint T line counts as positive, since any color there indicates the target substance was captured.
- Invalid: No line appears at the C position, regardless of whether a T line is visible. This means the liquid did not flow through the strip correctly and the test did not function. You need to repeat it with a new device.
One common source of confusion is line intensity. A very faint test line can mean a lower concentration of the target substance in your sample, but it still counts as a positive result. If you’re unsure whether you’re seeing a line or a shadow, testing again 24 to 48 hours later often produces a clearer result as the amount of antigen changes.
Accuracy Compared to Lab Tests
Lateral flow tests trade some accuracy for speed and convenience. The gold standard for many infections is PCR testing, which detects genetic material and amplifies it millions of times over, making it sensitive enough to pick up very small amounts of a pathogen. PCR results typically take hours in a lab. A lateral flow test detects proteins directly, with no amplification step, so it needs a higher concentration of the target substance to produce a visible line.
This difference shows up clearly in sensitivity data. A 2025 evaluation by the UK Health Security Agency tested 86 lateral flow devices for COVID-19 and found their sensitivity ranged from 32% to 83% when compared to PCR. That’s a wide gap. Many of those same devices had manufacturer-reported sensitivity claims of 85% or higher, with 49 of the 86 claiming sensitivity above 95%. The discrepancy highlights an important point: real-world performance often falls short of what’s listed on the box, particularly when samples contain lower levels of antigen (such as early or late in an infection).
Where lateral flow tests perform well is specificity, meaning they rarely produce false positives. When a lateral flow test says you’re positive, you very likely are. The weakness is false negatives: a negative result doesn’t guarantee you’re clear, especially if you tested early in the course of an illness or didn’t collect a good sample.
Why They’re Used Despite Lower Sensitivity
If lateral flow tests are less accurate than PCR, why use them at all? The answer comes down to access and timing. PCR tests require laboratory equipment, trained technicians, and hours of processing. In a fast-moving outbreak, those delays can mean someone is contagious for a full day or more before getting their result. Lateral flow tests deliver answers in 15 to 30 minutes, cost very little to manufacture, and require no special training.
This makes them valuable in a different way than PCR. They’re best at catching people with high viral loads, who are also the most likely to be contagious. Serial testing (repeating the test every day or two) compensates for the lower single-test sensitivity, because the amount of antigen rises as an infection progresses. Someone who tests negative on day one may test positive on day two or three when their antigen levels peak.
Uses Beyond COVID-19
The pregnancy test is the most familiar lateral flow device, and it works on exactly the same principle. Instead of detecting a viral protein, it detects a hormone (hCG) in urine. The technology is used across medicine and beyond: rapid strep tests at a doctor’s office, HIV screening in low-resource settings, malaria diagnosis in the field, and workplace drug testing panels all rely on lateral flow strips.
Outside of healthcare, the same platform is used to test food safety, detect environmental contaminants in water, and screen for bioterrorism agents. The core design stays the same. What changes is the antibody pair on the strip, which determines what substance the test is built to find.